https://www.gustaveroussy.fr/en/cancer-and-prevention/childhood-cancer/pediatric-research 2026-10-02T17:31:23+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/cancer-lenfant/recherche-pediatrie 2026-10-02T17:31:23+02:00 0.5 https://www.gustaveroussy.fr/en/activities-and-organizations 2026-09-09T11:28:25+02:00 0.5 https://www.gustaveroussy.fr/activites-associations 2026-09-09T11:28:25+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/prevention-and-diagnosis/cancer-prevention-research 2026-10-05T00:22:33+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/prevention-diagnostic/recherche-prevention-du-cancer 2026-10-05T00:22:33+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/breast-cancer/breast-cancer-diagnosis 2026-09-09T17:45:11+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-sein/diagnostic-du-cancer-du-sein 2026-09-09T17:45:11+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/breast-cancer/breast-cancer-treatments 2026-09-09T18:10:15+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-sein/traitements-du-cancer-du-sein 2026-09-09T18:10:15+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/sarcomas/treatments-for-sarcomas 2026-09-14T10:30:15+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/sarcomes/traitements-sarcomes 2026-09-14T10:30:15+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/neuroendocrine-tumors/treatments-for-neuroendocrine-tumors 2026-09-17T14:03:44+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/tumeurs-neuroendocrines/traitements-tumeurs-neuroendocrines 2026-09-17T14:03:44+02:00 0.5 https://www.gustaveroussy.fr/en/biography-of-jeremie-calais 2026-10-02T17:32:54+02:00 0.5 https://www.gustaveroussy.fr/jeremie-calais 2026-10-02T17:32:54+02:00 0.5 https://www.gustaveroussy.fr/en/gustave-roussy-institute 2026-10-02T14:05:49+02:00 0.5 https://www.gustaveroussy.fr/linstitut-gustave-roussy 2026-10-02T14:05:49+02:00 0.5 https://www.gustaveroussy.fr/en/governance-gustave-roussy 2026-10-04T17:56:47+02:00 0.5 https://www.gustaveroussy.fr/gouvernance-gustave-roussy 2026-10-04T17:56:47+02:00 0.5 https://www.gustaveroussy.fr/en/our-environmental-approach 2026-10-04T18:27:37+02:00 0.5 https://www.gustaveroussy.fr/notre-demarche-environnementale 2026-10-04T18:27:37+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/neuroendocrine-tumors/neuroendocrine-tumors-teams 2026-09-15T15:17:44+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/tumeurs-neuroendocrines/tumeurs-neuroendocrines-equipes 2026-09-15T15:17:44+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/supporting-innovation/gustave-roussy-transfer-accelerating-innovation-in 2026-09-24T17:20:18+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/accompagner-linnovation/gustave-roussy-transfert-accelerer-linnovation-contre 2026-09-24T17:20:18+02:00 0.5 https://www.gustaveroussy.fr/en/nous-soutenir/gustave-roussy-vous/donate-to-the-fight-against-cancer-financial-statements-and 2026-09-16T10:16:34+02:00 0.5 https://www.gustaveroussy.fr/nous-soutenir/gustave-roussy-vous/donner-contre-cancer-comptes-transparence 2026-09-16T10:16:34+02:00 0.5 https://www.gustaveroussy.fr/en/institutional-project-2026-2030 2026-10-04T17:57:59+02:00 0.5 https://www.gustaveroussy.fr/projet-detablissement-2026-2030 2026-10-04T17:57:59+02:00 0.5 https://www.gustaveroussy.fr/en/national-partnerships-a-network-of-excellence-serving-patients 2026-10-04T18:47:58+02:00 0.5 https://www.gustaveroussy.fr/partenariats-nationaux-reseau-dexcellence-au-service-patients 2026-10-04T18:47:58+02:00 0.5 https://www.gustaveroussy.fr/en/centralized-and-secure-access-to-the-investigational-drug-onc201-in-france 2026-09-21T11:27:08+02:00 0.5 https://www.gustaveroussy.fr/acces-centralise-securise-au-medicament-experimental-onc201-france 2026-09-21T11:27:08+02:00 0.5 https://www.gustaveroussy.fr/en/department-clinical-pharmacy-0 2026-10-04T18:50:44+02:00 0.5 https://www.gustaveroussy.fr/departement-pharmacie-clinique 2026-10-04T18:50:44+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/scientific-conferences-and-seminars/the-asco 2026-09-21T14:07:54+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/congres-seminaires-scientifiques/congres-lasco 2026-09-21T14:07:54+02:00 0.5 https://www.gustaveroussy.fr/en/head-and-neck-oncology-department 2026-09-22T09:12:32+02:00 0.5 https://www.gustaveroussy.fr/service-cancerologie-cervico-faciale 2026-09-22T09:12:32+02:00 0.5 https://www.gustaveroussy.fr/septembre 2026-09-22T11:53:55+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/preparing-your-visit/admission-and-pre-admission-procedures 2026-09-30T11:36:25+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/preparer-sa-venue/demarches-dadmission-pre-admission 2026-09-30T11:36:25+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/preparing-your-visit/preparing-for-my-hospital-stay 2026-10-04T19:35:47+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/preparer-sa-venue/preparer-mon-hospitalisation 2026-10-04T19:35:47+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/preparing-your-visit/preparing-for-my-appointment 2026-09-23T10:09:04+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/preparer-sa-venue/preparer-mon-rendez-vous 2026-09-23T10:09:04+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/healthcare/patient-experience-and-partnership 2026-09-23T15:20:44+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/experience-partenariat-patients 2026-09-23T15:20:44+02:00 0.5 https://www.gustaveroussy.fr/en/ask-second-opinion 2026-09-30T11:54:00+02:00 0.5 https://www.gustaveroussy.fr/patients-internationaux/patients-internationaux-demandez-deuxieme-avis 2026-09-30T11:54:00+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/healthcare/patient-rights/clinical-studies-and-trials 2026-09-25T09:39:09+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/droits-du-patient/etudes-essais-cliniques 2026-09-25T09:39:09+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/healthcare/patient-rights/expressing-your-choices 2026-09-24T18:11:50+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/droits-du-patient/expression-vos-choix 2026-09-24T18:11:50+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/the-future-research-building 2026-09-25T14:33:07+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/futur-batiment-recherche 2026-09-25T14:33:07+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/supporting-innovation/paris-saclay-cancer-cluster 2026-10-04T17:40:17+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/accompagner-linnovation/paris-saclay-cancer-cluster 2026-10-04T17:40:17+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/gouvernance-recherche/scientific-integrity 2026-09-30T10:02:36+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/gouvernance-recherche/integrite-scientifique 2026-09-30T10:02:36+02:00 0.5 https://www.gustaveroussy.fr/en/patients-internationaux/gustave-roussy-international 2026-10-05T10:01:00+02:00 0.5 https://www.gustaveroussy.fr/patients-internationaux/gustave-roussy-international 2026-10-05T10:01:00+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/call-for-applications 2026-09-28T10:15:27+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/appel-a-candidatures 2026-09-28T10:15:27+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/appel-a-candidatures/recruitment-of-principal 2026-09-28T10:16:18+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/healthcare/clinical-trials/the-specific-characteristics-of-a-clinical-trial 2026-10-04T19:33:27+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/essais-cliniques/specificites-dun-essai-clinique 2026-10-04T19:33:27+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/healthcare/clinical-trials/list-of-clinical-trials 2026-09-28T12:08:28+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/essais-cliniques/liste-essais-cliniques 2026-09-28T12:08:28+02:00 0.5 https://www.gustaveroussy.fr/en/patients-and-their-loved-ones/preparing-your-visit/practical-information/accessibility 2026-10-01T09:54:32+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/preparer-sa-venue/informations-pratiques/accessibilite 2026-10-01T09:54:32+02:00 0.5 https://www.gustaveroussy.fr/en/da-vinci-xi-robot-assisted-surgery-for-the-benefit-of-patients 2026-09-28T15:19:00+02:00 0.5 https://www.gustaveroussy.fr/da-vinci-xi-chirurgie-robot-assistee-au-service-patients 2026-09-28T15:19:00+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/adrenal-tumors/adrenal-cortical-carcinoma 2026-09-28T15:32:10+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/tumeurs-surrenale/corticosurrenalome 2026-09-28T15:32:10+02:00 0.5 https://www.gustaveroussy.fr/en/thoracic-committee 2026-10-04T20:27:48+02:00 0.5 https://www.gustaveroussy.fr/comite-du-thorax 2026-10-04T20:27:48+02:00 0.5 https://www.gustaveroussy.fr/en/endocrine-tumor-committee 2026-09-28T15:57:15+02:00 0.5 https://www.gustaveroussy.fr/comite-tumeurs-endocrines 2026-09-28T15:57:15+02:00 0.5 https://www.gustaveroussy.fr/en/sarcoma-committee 2026-10-04T20:07:03+02:00 0.5 https://www.gustaveroussy.fr/comite-sarcomes 2026-10-04T20:07:03+02:00 0.5 https://www.gustaveroussy.fr/en/oncogenetics-committee 2026-10-02T17:06:12+02:00 0.5 https://www.gustaveroussy.fr/comite-doncogenetique 2026-10-02T17:06:12+02:00 0.5 https://www.gustaveroussy.fr/en/neurology-committee 2026-10-04T20:06:19+02:00 0.5 https://www.gustaveroussy.fr/comite-neurologie 2026-10-04T20:06:19+02:00 0.5 https://www.gustaveroussy.fr/en/hematology-committee 2026-10-04T20:12:17+02:00 0.5 https://www.gustaveroussy.fr/comite-dhematologie 2026-10-04T20:12:17+02:00 0.5 https://www.gustaveroussy.fr/en/gynecologic-oncology-committee 2026-10-04T20:20:02+02:00 0.5 https://www.gustaveroussy.fr/comite-cancerologie-gynecologique 2026-10-04T20:20:02+02:00 0.5 https://www.gustaveroussy.fr/en/genitourinary-oncology-committee 2026-10-04T20:17:53+02:00 0.5 https://www.gustaveroussy.fr/comite-doncologie-genito-urinaire 2026-10-04T20:17:53+02:00 0.5 https://www.gustaveroussy.fr/en/gastroenterology-committee 2026-10-04T20:26:01+02:00 0.5 https://www.gustaveroussy.fr/comite-pathologies-digestives 2026-10-04T20:26:01+02:00 0.5 https://www.gustaveroussy.fr/en/breast-health-committee 2026-10-04T20:19:22+02:00 0.5 https://www.gustaveroussy.fr/comite-senologie 2026-10-04T20:19:22+02:00 0.5 https://www.gustaveroussy.fr/en/skin-cancer-committee 2026-10-04T20:10:29+02:00 0.5 https://www.gustaveroussy.fr/comite-cancers-peau 2026-10-04T20:10:29+02:00 0.5 https://www.gustaveroussy.fr/en/committee-on-childhood-and-adolescent-cancer 2026-10-04T20:27:22+02:00 0.5 https://www.gustaveroussy.fr/comite-cancerologie-lenfant-ladolescent 2026-10-04T20:27:22+02:00 0.5 https://www.gustaveroussy.fr/en/head-and-neck-committee-ent 2026-10-04T20:25:15+02:00 0.5 https://www.gustaveroussy.fr/comite-cervico-facial-orl 2026-10-04T20:25:15+02:00 0.5 https://www.gustaveroussy.fr/en/become-a-radiologic-technologist-at-gustave-roussy 2026-09-29T13:53:14+02:00 0.5 https://www.gustaveroussy.fr/devenir-manipulateur-a-gustave-roussy 2026-09-29T13:53:14+02:00 0.5 https://www.gustaveroussy.fr/en/becoming-a-nurse-at-gustave-roussy 2026-09-29T13:54:39+02:00 0.5 https://www.gustaveroussy.fr/devenir-infirmier-ou-infirmiere-a-gustave-roussy 2026-09-29T13:54:39+02:00 0.5 https://www.gustaveroussy.fr/en/professional-equality-a-concrete-commitment-at-gustave-roussy 2026-09-29T14:10:58+02:00 0.5 https://www.gustaveroussy.fr/legalite-professionnelle-engagement-concret-a-gustave-roussy 2026-09-29T14:10:58+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/clinical-research/cic1428-biotheris-clinical 2026-09-30T10:57:16+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/recherche-clinique/cic1428-biotheris-centre 2026-09-30T10:57:16+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/data-division 2026-10-04T19:59:43+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/pole-data 2026-10-04T19:59:43+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/search-platforms 2026-10-04T19:12:33+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/plateformes-recherche 2026-10-04T19:12:33+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/national-programs/the-mono-chem-project 2026-10-01T14:23:25+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-nationaux/projet-mono-chem 2026-10-01T14:23:25+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/national-programs/national-cohorts 2026-09-30T13:37:03+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes/programmes-nationaux/cohortes-nationales 2026-09-30T13:37:03+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-et-innovation/programmes/les-programmes-institutionnels/decript-programme-improving 2026-10-01T10:08:36+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes/programmes-institutionnels/programme-decript-mieux-comprendre-role 2026-10-01T10:08:36+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-et-innovation/programmes/les-programmes-institutionnels/inspire-programme-developing 2026-10-01T11:25:00+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes/programmes-institutionnels/programme-inspire-developper-organoides 2026-10-01T11:25:00+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/scientific-conferences-and-seminars/the-esmo 2026-10-01T11:41:56+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/congres-seminaires-scientifiques/congres-lesmo 2026-10-01T11:41:56+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/institutional-programs/cell-attack-program 2026-10-01T12:42:55+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-institutionnels/programme-cell 2026-10-01T12:42:55+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/institutional-programs/pancdemic-program 2026-10-01T12:45:16+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-institutionnels/programme-pancdemic 2026-10-01T12:45:16+02:00 0.5 https://www.gustaveroussy.fr/en/personal-information 2026-10-01T17:21:29+02:00 0.5 https://www.gustaveroussy.fr/donnees-personnelles 2026-10-01T17:21:29+02:00 0.5 https://www.gustaveroussy.fr/en/cookie-management 2026-10-02T11:54:58+02:00 0.5 https://www.gustaveroussy.fr/gestion-cookies 2026-10-02T11:54:58+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/european-programs/prevalung-eu-better 2026-10-01T17:59:31+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-europeens/prevalung-eu-mieux 2026-10-01T17:59:31+02:00 0.5 https://www.gustaveroussy.fr/en/sofia-rivera 2026-10-02T16:58:05+02:00 0.5 https://www.gustaveroussy.fr/sofia-rivera 2026-10-02T16:58:05+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/european-programs/erc-and-horizon-europe 2026-10-03T10:05:28+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-europeens/erc-horizon-europe 2026-10-03T10:05:28+02:00 0.5 https://www.gustaveroussy.fr/en/site-map 2026-10-03T10:51:39+02:00 0.5 https://www.gustaveroussy.fr/plan-site 2026-10-03T10:51:39+02:00 0.5 https://www.gustaveroussy.fr/biographie-juliette-gelard 2026-10-05T00:45:34+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer 2026-10-02T13:41:47+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer 2026-10-02T13:41:47+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/prevention-and-diagnosis/interception 2026-10-02T13:36:56+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/prevention-diagnostic/interception 2026-10-02T13:36:56+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/prevention-and-diagnosis 2026-09-29T17:37:29+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/prevention-diagnostic 2026-09-29T17:37:29+02:00 0.5 https://www.gustaveroussy.fr/en/join-us 2026-10-05T10:48:10+02:00 0.5 https://www.gustaveroussy.fr/nous-rejoindre 2026-10-05T10:48:10+02:00 0.5 https://www.gustaveroussy.fr/en/about-us 2026-10-05T01:44:08+02:00 0.5 https://www.gustaveroussy.fr/nous-connaitre 2026-10-05T01:44:08+02:00 0.5 https://www.gustaveroussy.fr/en/patients-and-their-loved-ones/be-taken-care 2026-10-02T17:46:06+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/etre-pris-charge 2026-10-02T17:46:06+02:00 0.5 https://www.gustaveroussy.fr/en/nous-soutenir/how-can-you-support-us 2026-09-29T11:50:14+02:00 0.5 https://www.gustaveroussy.fr/nous-soutenir/comment-nous-soutenir 2026-09-29T11:50:14+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/preparing-your-visit/practical-information 2026-10-04T18:48:25+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/preparer-sa-venue/informations-pratiques 2026-10-04T18:48:25+02:00 0.5 https://www.gustaveroussy.fr/en/2030-strategic-plan 2026-10-04T18:03:26+02:00 0.5 https://www.gustaveroussy.fr/plan-strategique-institutionnel-2030 2026-10-04T18:03:26+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/childhood-cancer 2026-09-25T14:24:02+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/cancer-lenfant 2026-09-25T14:24:02+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/childhood-cancer/cancers-in-children-and-adolescents 2026-09-11T10:26:50+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/cancer-lenfant/cancers-enfants-adolescents 2026-09-11T10:26:50+02:00 0.5 https://www.gustaveroussy.fr/en/nous-soutenir/how-can-you-support-us/our-highlights-solidarity 2026-10-05T09:54:23+02:00 0.5 https://www.gustaveroussy.fr/nous-soutenir/comment-nous-soutenir/nos-temps-forts-solidaires 2026-10-05T09:54:23+02:00 0.5 https://www.gustaveroussy.fr/en/support-us/gustave-roussy-and-you 2026-09-30T16:56:06+02:00 0.5 https://www.gustaveroussy.fr/nous-soutenir/gustave-roussy-vous 2026-09-30T16:56:06+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/scientific-conferences-and-seminars 2026-10-01T12:13:50+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/congres-seminaires-scientifiques 2026-10-01T12:13:50+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/gustave-roussys-research/clinical-research 2026-10-02T17:34:52+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-gustave-roussy/recherche-clinique 2026-10-02T17:34:52+02:00 0.5 https://www.gustaveroussy.fr/en/patients-et-proches/healthcare 2026-10-04T19:33:30+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins 2026-10-04T19:33:30+02:00 0.5 https://www.gustaveroussy.fr/en/patients-et-proches/preparing-your-visit 2026-10-04T22:44:40+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/preparer-sa-venue 2026-10-04T22:44:40+02:00 0.5 https://www.gustaveroussy.fr/en/patients-and-their-loved-ones/healthcare/clinical-trials-advancing-research-today-and-tomorrow 2026-10-04T19:31:39+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/essais-cliniques-faire-avancer-recherche-aujourdhui-demain 2026-10-04T19:31:39+02:00 0.5 https://www.gustaveroussy.fr/en/patients-and-their-loved-ones/follow-and-daily-life 2026-10-02T17:55:52+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/suivi-vie-quotidienne 2026-10-02T17:55:52+02:00 0.5 https://www.gustaveroussy.fr/en/nous-soutenir/become-a-patron 2026-09-16T14:33:31+02:00 0.5 https://www.gustaveroussy.fr/nous-soutenir/devenir-mecene 2026-09-16T14:33:31+02:00 0.5 https://www.gustaveroussy.fr/en/patients-et-proches/healthcare/cancer-treatments 2026-10-02T17:42:08+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/traitements-du-cancer 2026-10-02T17:42:08+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/soins/traitements-du-cancer/immunotherapy 2026-09-08T11:36:25+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/traitements-du-cancer/limmunotherapie 2026-09-08T11:36:25+02:00 0.5 https://www.gustaveroussy.fr/en/patients-proches/soins/traitements-du-cancer/surgery 2026-09-24T13:31:24+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/traitements-du-cancer/chirurgie 2026-09-24T13:31:24+02:00 0.5 https://www.gustaveroussy.fr/en/our-entities 2026-10-04T17:52:09+02:00 0.5 https://www.gustaveroussy.fr/nos-entites 2026-10-04T17:52:09+02:00 0.5 https://www.gustaveroussy.fr/en/key-dates-in-the-life-of-gustave-roussy 2026-09-24T12:23:41+02:00 0.5 https://www.gustaveroussy.fr/dates-cles-gustave-roussy 2026-09-24T12:23:41+02:00 0.5 https://www.gustaveroussy.fr/en/training-better-care 2026-10-02T17:47:37+02:00 0.5 https://www.gustaveroussy.fr/former-mieux-soigner 2026-10-02T17:47:37+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention 2026-09-21T14:30:30+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention 2026-09-21T14:30:30+02:00 0.5 https://www.gustaveroussy.fr/en/support-us 2026-09-21T14:37:01+02:00 0.5 https://www.gustaveroussy.fr/nous-soutenir 2026-09-21T14:37:01+02:00 0.5 https://www.gustaveroussy.fr/en/patients-et-proches/healthcare/support-and-palliative-care 2026-10-02T17:43:18+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/accompagnement-soins-support 2026-10-02T17:43:18+02:00 0.5 https://www.gustaveroussy.fr/en/patients-et-proches/healthcare/patient-rights 2026-10-02T17:43:34+02:00 0.5 https://www.gustaveroussy.fr/patients-proches/soins/droits-du-patient 2026-10-02T17:43:34+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/supporting-innovation 2026-10-04T22:23:55+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/accompagner-linnovation 2026-10-04T22:23:55+02:00 0.5 https://www.gustaveroussy.fr/en/gustave-roussys-research 2026-10-04T20:37:39+02:00 0.5 https://www.gustaveroussy.fr/recherche-gustave-roussy 2026-10-04T20:37:39+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/programmes-medico-scientifiques/national-programs 2026-10-01T11:51:06+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-nationaux 2026-10-01T11:51:06+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/programmes-medico-scientifiques/institutional-programs 2026-10-01T12:41:52+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-institutionnels 2026-10-01T12:41:52+02:00 0.5 https://www.gustaveroussy.fr/en/research-and-innovation/medical-scientific-programmes/european-programs 2026-10-03T10:07:52+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/programmes-medico-scientifiques/programmes-europeens 2026-10-03T10:07:52+02:00 0.5 https://www.gustaveroussy.fr/en/press/innovation-ai-digital-health/first-in-france-scarless-robot-assisted-thyroid-lobectomy 2016-11-22T11:51:41+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/aacr-project-genie-publicly-releases-large-cancer-genomic-data 2017-01-05T17:36:59+01:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/donnees-genomiques-19-000-patients-rassemblees-immense-base 2017-01-05T17:36:59+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/frederic-varnier-est-nomme-directeur-general-adjoint 2017-01-17T11:37:19+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/bilan-perspectives-special-immunotherapie 2020-12-10T18:09:35+01:00 0.5 https://www.gustaveroussy.fr/en/press/when-meals-make-the-daily-lives-of-patients-easier 2026-08-11T09:44:11+02:00 0.5 https://www.gustaveroussy.fr/presse/quand-repas-adoucit-quotidien-malades 2026-08-11T09:44:11+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pocket-lappli-collaborateurs-gustave-roussy 2018-04-19T16:59:25+02:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/inivata-and-gustave-roussy-publish-positive-results-from 2017-03-30T17:05:45+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/medecins-chercheurs-gustave-roussy-apportent-preuve 2017-04-03T15:51:13+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/composition-du-microbiote-intestinal-predit-lefficacite 2020-12-10T18:05:59+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/predire-lefficacite-dun-traitement-cancer-du-poumon-grace-a 2017-05-02T12:17:48+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2017-metastatic-melanoma-pd1-blocking-immunotherapy 2024-04-16T15:11:07+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2017-melanome-metastatique-immunotherapie-nouvelle-generation 2024-04-16T15:11:07+02:00 0.5 https://www.gustaveroussy.fr/en/press/asco-2017-press-releases 2017-06-03T13:36:40+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/asco-2017-communiques-presse 2017-06-03T13:36:40+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2017-major-results-in-metastatic-prostate-cancer-treatment 2024-04-16T15:14:13+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2017-cancer-grave-prostate-une-augmentation-des-chances-de-survie 2024-04-16T15:14:13+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2017-a-new-predictive-test-for-the-risk-of-relapse-in 2024-04-16T15:12:47+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2017-nouveau-test-predictif-du-risque-rechute-cancer 2024-04-16T15:12:47+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/gustave-roussy-a-lasco-2017-dossier-presse 2017-05-30T15:22:29+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/resultats-encourageants-dune-immunotherapie-contre-cancers 2024-04-16T15:15:36+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2017-resultats-encourageants-dune-immunotherapie-contre-les-cancers-gynecologiques 2024-04-16T15:15:36+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/france-inter-lolympia-credit-mutuel-sassocient-au-collectif-ensemble-contre 2017-06-15T18:07:06+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/discovery-of-a-new-mechanism-involved-in-the-migration-of-cancer 2021-09-13T09:50:53+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/un-nouveau-mecanisme-implique-dans-la-migration-des-cellules-cancereuses 2021-09-13T09:50:53+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/le-dr-christophe-massard-prend-la-direction-du-ditep 2024-01-17T15:21:57+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/selection-du-projet-seqoia-porte-lap-hp-linstitut-curie 2017-07-17T18:43:43+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/fondation-gustave-roussy-lance-grande-campagne-dediee-au 2022-09-21T10:51:10+02:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/gustave-roussy-devoile-resultats-du-1er-barometre-francais-legs 2017-11-15T11:27:33+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/sac-a-dos-accompagner-retour-a-lecole-enfants-atteints 2017-09-18T16:04:06+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/37-000-personnes-mobilisees-530-000-euros-collectes-lors 2017-10-03T16:36:32+02:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/gustave-roussy-presente-resultats-positifs-letude-clinique-riviera 2017-10-16T11:52:22+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/bateau-aux-couleurs-gustave-roussy-transat-jacques-vabre 2017-10-27T12:25:40+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/antibiotics-affect-the-efficacy-of-immunotherapy 2017-11-03T12:13:05+01:00 0.5 https://www.gustaveroussy.fr/presse/antibiotiques-perturbent-lefficacite-limmunotherapie 2017-11-03T12:13:05+01:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/5e-open-gustave-roussy-au-golf-saint-cloud 2017-11-09T18:17:11+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/natixis-gustave-roussy-racing-92-mobilises-ensemble-contre 2017-11-13T16:35:11+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/admirable-arrivee-du-gustave-roussy-transat-jacques-vabre 2020-11-27T15:07:51+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/gustave-roussy-msd-france-signent-accord-dalliance 2018-01-09T10:48:36+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-gustave-roussy-transfert-satt-paris-saclay-signent-convention 2018-02-05T16:13:32+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/cancers-du-cerveau-lenfant-moins-orphelins 2018-02-14T11:03:04+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/soutenue-nicolas-sarkozy-vente-aux-encheres-orducommun-a 2018-02-15T14:30:09+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/gustave-roussy-centralesupelec-signent-accord-renforcer-leur 2018-02-19T15:36:54+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/chirurgie-assistee-robot-gustave-roussy-signe-premiere 2018-02-27T15:57:56+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/premiere-mondiale-a-lhopital-necker-enfants-malades 2018-04-09T11:05:02+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-and-protagen-ag-collaborate-to-improve-the-risk-profiling-of 2018-04-10T16:05:11+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/aacr-2018-limmunotherapie-diminue-risque-rechute-du-melanome 2020-12-10T17:50:59+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/pep-therapy-institut-curie-and-gustave-roussy-obtain-29-meur-to-develop-a-novel 2018-04-17T15:48:11+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/pep-therapy-linstitut-curie-gustave-roussy-obtiennent-29 2018-04-17T15:48:11+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/death-of-professor-thomas-tursz 2018-05-07T11:00:06+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/disparition-du-professeur-thomas-tursz 2018-05-07T11:00:06+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2018-press-releases 2018-06-04T16:59:16+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/asco-2018-communiques-presse 2018-06-04T16:59:16+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/bonnes-fees-maeva-coucke-inaugurent-ateliers-rose-danse-a 2018-05-29T15:17:43+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/gustave-roussy-a-lasco-2018-dossier-presse 2018-05-31T11:50:01+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2018-resultats-du-projet-acse-crizotinib-presentes-au 2018-06-01T21:44:35+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2018-validation-of-the-efficacy-of-trabectedin-in 2018-05-31T17:18:48+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2018-validation-lefficacite-trabectedine-sarcomes 2018-05-31T17:18:48+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2018-pres-13-guerison-plus-enfants-adolescents 2018-06-03T19:51:15+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-reduit-son-deficit-moitie 2018-06-14T16:21:55+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-sequipe-deux-robots-preparation-automatisee-chimiotherapies 2018-06-19T14:40:07+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/15092018-ascension-orducommun 2018-07-10T14:19:02+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/thanks-to-13-million-euros-support-funding-from-the-fondation-arc-gustave 2018-07-13T16:16:53+02:00 0.5 https://www.gustaveroussy.fr/presse/prix-distinctions/grace-au-soutien-13-million-deuros-fondation-arc-gustave-roussy-recrute 2018-07-13T16:16:53+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/researchers-map-family-trees-of-acute-myeloid-leukaemia-for-the 2018-07-17T11:48:39+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/premiere-fois-chercheurs-etablissent-larbre-genealogique 2018-07-17T11:48:39+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/predicting-the-response-to-immunotherapy-using-artificial 2018-08-27T09:40:36+02:00 0.5 https://www.gustaveroussy.fr/presse/predire-reponse-limmunotherapie-grace-ia 2018-08-27T09:40:36+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/septembre-grande-mobilisation-aux-cotes-gustave-roussy 2020-12-10T17:48:35+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/37-500-personnes-mobilisees-520-000-euros-collectes-lors 2018-10-09T11:24:25+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/radiotherapie-defendre-ladn-proteines-partent-quete-lanneau 2018-10-10T17:19:04+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2018-gustave-roussy-presentations 2018-10-19T12:34:04+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/esmo-2018-presentations-gustave-roussy 2018-10-19T12:34:04+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2018-first-evidence-of-the-beneficial-effect-of-a-new-drug 2018-10-20T16:39:16+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2018-nouveau-medicament-guide-anomalie-du-genome-fait 2018-10-20T16:39:16+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/ouverture-france-lessai-therapeutique-bob-du-consortium 2018-11-08T14:06:38+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/immunotherapie-nouvelle-voie-moduler-reponse-immunitaire 2018-11-08T15:10:39+01:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/6e-open-gustave-roussy-golf-saint-cloud 2018-11-13T10:21:50+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/gustave-roussy-therapanacea-centralesupelec-creent-laboratoire 2018-12-03T16:11:31+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/plagne-1ere-station-solidaire-contre-cancer-aux-cotes 2018-12-19T10:16:07+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/journee-internationale-du-cancer-lenfant-rodin-va-a-lhopital 2019-01-29T17:44:11+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/mesurer-lempreinte-immunitaire-predire-pronostic-femmes 2019-01-28T15:42:05+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/course-odyssea-samedi-2-fevrier-2019 2021-05-10T14:18:41+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-and-the-institut-bergonie-partners-for-early-phase-trials-and 2019-02-12T17:52:48+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/gustave-roussy-linstitut-bergonie-partenaires-recherche-clinique 2019-02-12T17:52:48+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/attention-a-lutilisation-dun-traitement-contre-reflux-acide 2019-02-14T10:11:31+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/deux-annees-gagnees-propagation-maladie-patients-atteints 2019-02-15T17:32:55+01:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/xentech-signs-strategic-collaboration-agreement-with-gustave 2019-03-28T17:16:52+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/xentech-noue-partenariat-strategique-gustave-roussy 2019-03-28T17:16:52+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-lance-ambitieux-plan-dinvestissement-250-millions-deuros 2019-04-04T13:58:50+02:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/gustave-roussy-sequipe-dun-nouveau-plateau-high-tech-radiologie 2019-04-15T11:39:54+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-presente-resultat-financier-2018-excedentaire 2019-05-06T18:20:17+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cancers-du-sein-avances-sont-genetiquement-plus-complexes 2019-05-23T09:33:08+02:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/asco-2019-gustave-roussys-presentations-highlights 2019-06-03T14:38:32+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/gustave-roussy-au-congres-a-lasco-2019-dossier-presse 2019-06-03T14:38:32+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2019-prostate-cancer-darolutamide-reduces-the-risk-of-pain 2024-05-16T10:51:24+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2019-cancer-prostate-darolutamide-reduit-risque 2024-05-16T10:51:24+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2019-artificial-intelligence-can-predict-the-chances-of 2024-05-16T10:50:57+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2019-intelligence-artificielle-permet-predire-risque 2024-05-16T10:50:57+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/asco-2019-larotrectinib-first-targeted-therapy-for-childhood-solid 2024-05-16T10:50:33+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2019-larotrectinib-premiere-therapie-ciblee-tumeurs 2024-05-16T10:50:33+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2019-urothelial-cancer-bladder-and-urinary-tract-new 2019-06-03T22:35:18+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2019-cancer-urothelial-vessie-voies-urinaires 2019-06-03T22:35:18+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2019-melanoma-the-advantages-of-targeted-dual-therapy 2024-05-16T10:49:57+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2019-melanome-benefices-dune-bitherapie-ciblee 2024-05-16T10:49:57+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/evaluation-reintroduction-dune-immunotherapie-anti-pd-1 2019-06-14T10:02:01+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-reaffirms-its-commitment-to-research-integrity 2019-06-28T16:13:55+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-reaffirme-son-attachement-a-lintegrite-scientifique 2019-06-28T16:13:55+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/microbiome-cancer-the-oncobiome-consortium-led-by-gustave-roussy 2019-06-27T17:04:19+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/microbiome-cancer-consortium-oncobiome-pilote-gustave 2019-06-27T17:04:19+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/14092019-ascension-orducommun 2019-07-18T15:17:36+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/suite-au-reportage-france-2 2019-07-25T21:14:57+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/stephane-pardoux-nomme-directeur-general-adjoint-gustave-roussy 2019-09-02T14:41:24+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/decouverte-dune-nouvelle-opportunite-traitement-cancer-grave-du-cerveau-lenfant 2019-09-09T17:45:51+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/resistance-a-radiotherapie-dune-forme-grave-cancer-du-cerveau-lenfant-mieux 2019-09-16T10:57:10+02:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/cancer-du-sein-mieux-depister-mieux-soigner-ouverture-letude 2019-09-17T15:56:16+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pr-alexander-eggermont-directeur-general-gustave-roussy-octobre-2010-prend 2019-09-23T09:59:16+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/il-est-encore-temps-sinscrire-a-course-marche-odyssea-paris 2019-09-24T10:55:18+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2019-cancer-du-poumon-mute-egfr-7-mois-vie-gagnes 2019-09-30T11:40:43+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pr-michel-ducreux-est-nomme-directeur-general-interim-gustave-roussy 2019-10-01T17:33:27+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2019-cancer-prostate-metastatique-resistant-a 2019-10-02T16:19:03+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/36-000-participants-mobilises-635-000-euros-collectes-lors 2019-10-09T14:57:56+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/breast-cancer-hormone-therapy-has-a-bigger-impact-than 2019-10-09T10:14:11+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cancer-du-sein-lhormonotherapie-a-impact-plus-important-que 2019-10-09T10:14:11+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/pediatric-cancers-why-some-forms-of-leukemia-only-affect-children 2019-10-30T14:23:58+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/cancers-pediatriques-pourquoi-certaines-leucemies-touchent-uniquement-enfants 2019-10-30T14:23:58+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/vaccin-lever-resistance-aux-immunotherapies 2019-11-05T18:49:34+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/developpement-medicaments-ia-prevoit-succes-dune-molecule 2019-11-25T11:29:56+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/letude-biomede-demontre-limportance-du-sequencage-au-diagnostic-dune-tumeur-au 2019-12-04T17:33:03+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/repas-fetes-fin-dannee-a-gustave-roussy 2019-12-12T13:27:29+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/professor-jean-charles-soria-appointed-general-director-of-gustave-roussy 2019-12-16T12:46:25+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/professeur-jean-charles-soria-nomme-directeur-general-gustave-roussy 2019-12-16T12:46:25+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/intelligence-artificielle-oncologie-alliance-strategique-entre 2019-12-19T12:22:13+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/femme-cinq-ne-reprend-pas-travail-an-apres-fin-traitements 2019-12-20T15:41:38+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/groupement-de-cooperation-sanitaire-cancers-thorax 2021-12-24T10:57:46+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/professor-fabrice-barlesi-becomes-gustave-roussy-medical-director 2020-01-16T15:40:25+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/professeur-fabrice-barlesi-nomme-directeur-medical-gustave-roussy 2020-01-16T15:40:25+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/marcher-courir-skier-surfer-sport-arme-contre-cancer-plagne 2020-01-29T09:30:43+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/mobilisation-record-plus-3-millions-deuros-collectes 2020-01-28T15:43:00+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/professor-fabrice-andre-appointed-as-research-director-at-gustave-roussy 2020-02-11T17:06:38+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pr-fabrice-andre-nomme-directeur-recherche-gustave-roussy 2020-02-11T17:06:38+01:00 0.5 https://www.gustaveroussy.fr/en/press/innovation-ai-digital-health/artificial-intelligence-in-oncology-strategic-alliance-between 2020-02-10T17:45:23+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/cancer-lenfant-premiers-resultats-deux-grands-essais-cliniques-immunotherapie 2020-02-13T17:36:03+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/pr-antoine-italiano-institut-bergonie-joins-gustave-roussy-to-head-the 2020-02-27T17:57:20+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/professeur-antoine-italiano-institut-bergonie-rejoint 2020-02-27T17:57:20+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/mars-bleu-organoides-au-secours-cancers-digestifs 2020-12-10T14:08:19+01:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/cohorte-e3n-e4n-obtient-financement-3-millions-deuros 2020-03-03T14:18:58+01:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/nouveau-departement-interdisciplinaire-dedie-au-parcours 2020-09-16T14:44:32+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-se-transforme-continuer-a-accueillir-patients-atteints-cancer 2020-12-10T14:06:08+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/medecine-precision-2e-generation-lancement-prism-centre 2020-04-14T10:09:26+02:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/capri-covid-solution-telesuivi-patients-atteints-cancer-issue 2020-04-15T15:14:25+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nature-medicine-adaptation-prises-charge-du-cancer-contexte 2020-04-17T16:59:59+02:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/ralph-lauren-lance-donation-initiative-collecte-fonds-soutenir-gustave 2020-04-23T16:31:51+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/gustave-roussy-presente-pleniere-laacr-son-analyse-retour 2020-04-29T09:40:26+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2020-soft-tissue-sarcomas-combined-therapy-with-doxorubicin 2020-05-29T15:53:56+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2020-sarcomes-tissus-mous-lassociation-doxorubicine 2020-05-29T15:53:56+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2020-the-capri-program-proves-its-clinical-and-economic 2020-05-29T15:48:55+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2020-dispositif-capri-prouve-son-efficacite-clinique 2020-05-29T15:48:55+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nature-medicine-petit-intestin-regule-surveillance 2020-06-10T16:42:59+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/asco-2020-childhood-cancers-early-promising-results-of-a-dual-therapy-in 2020-05-29T15:53:19+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2020-cancers-pediatriques-premiers-resultats 2020-05-29T15:53:19+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2020-lung-cancers-hopes-for-conjugated-antibodies 2020-05-29T15:52:43+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2020-cancers-du-poumon-lespoir-anticorps-conjugues 2020-05-29T15:52:43+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/docteur-jean-michel-heard-est-nomme-secretaire-general-recherche-gustave 2020-06-02T10:23:27+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2020-breast-cancers-certain-genetic-abnormalities-might 2020-05-31T11:39:56+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2020-cancers-du-sein-certaines-alterations-genetiques 2020-05-31T11:39:56+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/a-new-immunotherapeutic-agent-for-children-and-adolescents-with 2020-06-04T12:28:12+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nouveau-traitement-dimmunotherapie-enfants-adolescents 2020-06-04T12:28:12+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/journal-of-clinical-oncology-femmes-jeunes-rechutent-plus 2020-06-23T17:53:35+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/premiere-destruction-metastases-au-foie-guidee-robot 2026-08-13T11:58:54+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/daiichi-sankyo-gustave-roussy-concluent-accord 2020-07-23T18:33:22+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/daiichi-sankyo-and-gustave-roussy-enter-innovative-research-collaboration-for 2020-07-23T18:42:04+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/identification-dune-nouvelle-cible-therapeutique 2023-03-28T11:08:19+02:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/gustave-roussy-lieu-sante-tabac 2020-12-10T14:01:11+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nejm-darolutamide-augmente-survie-patients-atteints-dun 2020-09-10T16:58:24+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2020-injection-dimmunotherapie-elimine-moitie-cellules 2020-12-10T10:39:31+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2020-covid-19-surmortalite-cancers-lors-premiere-vague 2020-12-10T10:38:55+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/gustave-roussy-contribue-a-definir-nouveau-biomarqueur 2020-09-17T14:26:26+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2020-cancers-du-poumon-linteret-dune-radiotherapie 2020-12-10T10:37:48+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2020-premiers-resultats-du-projet-pioneer-plus-vaste 2020-12-10T10:40:10+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/magazine-newsweek-place-gustave-roussy-top-5-mondial-meilleurs-hopitaux 2020-10-06T16:08:41+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/octobre-rose-lancement-ledition-connectee-odyssea-paris 2020-12-10T14:00:06+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/travaux-montrent-que-traitement-hormone-croissance-enfants-gueris-dun-cancer 2020-09-29T14:10:01+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/worlds-best-specialized-hospitals-2021-newsweek-magazine-places-gustave-roussy 2020-10-06T16:46:42+02:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/8e-open-gustave-roussy-golf-saint-cloud 2020-10-27T11:33:53+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/anticiper-complications-aigues-covid-19-quand-ia-peut 2020-12-24T15:19:33+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/pediatric-cancer-researchers-receive-13-million-to-study-precise-treatment-for 2020-11-16T16:04:28+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/recherche-pediatrique-oncologie-va-recevoir-13-million-dollars-evaluer-therapie 2020-11-16T16:04:28+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/plasmatherapie-traitement-covid-19-certains-patients 2020-11-30T09:48:44+01:00 0.5 https://www.gustaveroussy.fr/en/press/innovation-ai-digital-health/ai-powered-solution-to-optimize-the-response-to-radiation 2020-12-07T17:45:50+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/therapanacea-gustave-roussy-lap-hp-licans-institut 2020-12-07T17:45:50+01:00 0.5 https://www.gustaveroussy.fr/presse/prix-distinctions/centre-leon-berard-gustave-roussy-sengagent-partenariat-strategique 2020-12-17T17:06:55+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nouveau-pas-franchi-future-indication-limmunotherapie 2021-01-21T13:51:50+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/lintelligence-artificielle-guide-prise-charge-plus-anticipee 2021-01-29T09:30:36+01:00 0.5 https://www.gustaveroussy.fr/en/press/public-health-prevention/gustave-roussy-is-launching-a-groundbreaking-cancer-screening 2026-09-09T18:33:34+02:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/gustave-roussy-lance-programme-inedit-dinterception-cancers 2026-09-09T18:33:34+02:00 0.5 https://www.gustaveroussy.fr/presse/prix-distinctions/valerie-pecresse-rencontre-equipes-gustave-roussy-dowkin-laureat-du-ai-for 2021-02-04T15:17:50+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/coup-daccelerateur-sauver-plus-denfants-du-cancer 2021-02-13T11:53:26+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/ovarian-cancer-drug-offers-new-genetically-targeted-approach 2021-04-27T16:28:11+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-joins-the-worldwide-innovative-network-win-in-personalized 2021-04-30T15:27:51+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/gustave-roussy-rejoint-consortium-worldwide-innovative 2021-04-30T15:27:51+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2021-metastatic-recurrent-cancer-of-the-uterine-cervix 2021-06-04T16:32:31+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2021-cancer-col-uterus-resultats-encourageants-immunotherapie 2021-06-04T16:32:31+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2021-relapsed-refractory-acute-myeloid-leukaemia-hope-for 2021-06-04T16:33:05+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2021-leucemie-myeloide-aigue-espoir-remissions-therapie-ciblee-orale 2021-06-04T16:33:05+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2021-prostate-cancer-with-metastases-at-the-time-of 2021-06-08T15:09:27+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2021-cancer-de-la-prostate-combiner-hormonotherapies-et-chimiotherapie 2021-06-08T15:09:27+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/prise-en-charge-cancers-chu-lareunion-et-gustave-roussy-convention-cadre 2021-06-02T14:47:52+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/le-groupe-hospitalier-paris-saint-joseph-et-gustave-roussy-lancent-le-citc 2026-09-08T14:11:07+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/orphelia-pharma-and-gustave-roussy-announce-issuance-of-european 2021-06-17T09:52:57+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/orphelia-pharma-gustave-roussy-brevet-europeen-kimozor 2021-06-17T09:52:57+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/creation-dun-biocluster-oncologie-centre-patient 2021-12-24T10:55:31+01:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/creation-of-a-patient-centered-biocluster-in-oncology 2021-06-30T10:33:57+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/gustave-roussy-fabrx-collaborent-developper-limpression-3d 2021-07-01T17:22:07+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/professor-fabrice-barlesi-is-appointed-general-director-of-gustave-roussy 2021-07-30T18:57:57+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pr-fabrice-barlesi-est-nomme-directeur-general-gustave-roussy 2021-07-30T18:57:57+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/septembre-nattendons-pas-mobiliser-societe-civile 2021-08-31T17:49:00+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/nominations-a-direction-gustave-roussy 2021-09-06T15:33:44+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/speeding-up-breast-cancer-diagnosis-in-egypt-ge-healthcare-gustave-roussy-and 2021-09-07T16:01:18+02:00 0.5 https://www.gustaveroussy.fr/presse/international/ge-healthcare-gustave-roussy-ministere-sante-egyptien-sassocient-accelerer 2021-09-07T16:01:18+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2021-artificial-intelligence-predicts-the-risk-of 2021-09-21T17:17:42+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2021-ia-predit-risque-rechute-femmes-atteintes-du 2021-09-21T17:17:42+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/sylvain-ducroz-est-nomme-directeur-general-adjoint-gustave-roussy 2021-09-20T11:20:20+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2021-first-scientific-evidence-for-effectiveness-of-a 2021-09-23T14:12:02+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2021-premieres-preuves-scientifiques-lefficacite-dun 2021-09-23T14:12:02+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2021-lung-cancers-a-vaccine-demonstrates-encouraging 2021-09-23T14:27:27+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2021-cancers-du-poumon-vaccin-montre-resultats 2021-09-23T14:27:27+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/si-digital-limitait-risque-recidive-dun-cancer-du-sein 2021-09-23T11:43:26+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/new-startup-aglaia-therapeutics-raises-eur4m-in-seed-funding-to-overcome 2021-09-28T12:20:24+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/startup-aglaia-therapeutics-leve-4-millions-euros-resistance-therapies-ciblees-cancer 2021-09-28T12:20:24+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/gustave-roussy-inaugure-sa-nouvelle-unite-dediee-aux-adolescents-atteints 2022-01-12T11:17:34+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/gustave-roussy-inaugure-sa-nouvelle-unite-dediee-aux-adolescents-atteints-cancer 2022-01-12T11:17:34+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/odyssea-paris-2021-collecte-472-000-euros-recherche-contre 2021-10-05T10:44:00+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/sengine-precision-medicine-and-gustave-roussy-announce-plan-to-launch-parisr 2021-10-06T10:36:44+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/medecine-personnalisee-gustave-roussy-sengine-precision-medicine-test-personnalise 2021-10-06T10:36:44+02:00 0.5 https://www.gustaveroussy.fr/presse/decryptage/octobre-rose-radiotherapie-5-jours-gustave-roussy-transforme-prise-charge-du 2021-10-08T08:29:20+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/gustave-roussy-lance-programme-compass-contre-cancer-du 2021-10-14T18:07:21+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-and-lxrepair-announce-a-partnership-for-personalized 2021-10-21T14:31:13+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/gustave-roussy-lxrepair-annoncent-partenariat-radiotherapie 2021-10-21T14:31:13+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/a-loccasion-son-premier-congres-centre-international-cancers 2021-11-10T11:26:36+01:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/accelerer-recherche-sciences-humaines-sociales-oncologie 2021-12-07T14:19:36+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cancer-sein-metastatique-sequencage-genomique 2021-12-09T17:15:51+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/26-millions-deuros-collectes-recherche-cancers-pediatriques 2026-08-11T09:56:33+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/centrale-production-pharmaceutique-robotisee-derniere 2026-09-21T11:52:21+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/quatre-projets-majeurs-programme-investissements-davenir 2021-12-15T15:58:09+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/cancer-treatment-identification-of-the-blood-vessels-that-allow 2022-02-03T17:34:29+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/traitement-du-cancer-identification-vaisseaux-sanguins-qui 2022-02-03T17:34:29+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/the-paris-saclay-cancer-cluster-association-announces-its-official-creation 2022-02-08T15:37:16+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/lassociation-paris-saclay-cancer-cluster-annonce-sa-creation 2022-02-08T15:37:16+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/algorithme-predire-fatigue-severe-diagnostic-cancer-du-sein 2022-02-09T17:04:26+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/lancement-lobservatoire-national-syndromes-predisposition-aux-cancers-pediatriques 2022-02-15T18:21:36+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/lespoir-nouvelles-therapeutiques-grace-au-sequencage-du-genome-tumoral 2022-03-17T16:54:24+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/pas-benefice-liode-radioactif-cancer-thyroide-a-faible 2022-03-22T17:24:31+01:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/souliers-vie 2022-03-29T17:06:51+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/hopital-mon-doudou-sinstalle-premiere-fois-service-donco-pediatrie-a-gustave 2022-08-23T10:28:09+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-luniversite-paris-saclay-signent-convention-renforcer-leurs 2022-04-07T13:57:14+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-present-au-salon-infirmier 2022-04-22T14:13:05+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/suivi-digital-patients-atteints-cancer-a-scientifiquement 2026-08-11T09:47:15+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/combinaison-therapeutique-devient-reference-traitement 2026-08-11T09:45:27+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/2002-2022-dosisoft-delivering-20-years-of-innovation 2022-05-10T10:41:22+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/2002-2022-dosisoft-produit-20-ans-d-innovation 2022-05-10T10:41:22+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/etude-peace1-lancet-pronostic-patients-atteints-cancer-prostate 2022-05-18T16:51:07+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2022-a-promising-targeted-therapy-for-treatment-of-relapses 2022-06-21T14:49:49+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2022-lenasidenib-therapie-ciblee-prometteuse-rechutes 2022-06-21T14:49:49+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2022-ragnar-study-the-benefits-of-targeted-therapy-beyond 2022-06-21T14:59:38+02:00 0.5 https://www.gustaveroussy.fr/presse/asco-2022-etude-ragnar-benefices-dune-therapie-ciblee-au-dela-du-cancer-vessie 2022-06-21T14:59:38+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/asco-2022-the-sacha-study-supports-the-use-of-innovative-anticancer 2022-06-21T15:25:42+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2022-letude-sacha-securise-lutilisation-enfants 2022-06-21T15:25:42+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/dana-farber-cancer-institute-gustave-roussy-and-linstitut-servier-sign-an 2022-06-07T10:51:38+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2022-2-in-1-immunotherapy-in-advanced-kidney-cancer 2022-06-21T15:43:44+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2022-immunotherapie-2-1-cancer-du-rein-avance 2022-06-21T15:43:44+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/orphelia-pharma-and-gustave-roussy-announce-the-publication-in-pharmaceuticals 2022-06-09T15:05:10+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/orphelia-pharma-gustave-roussy-annoncent-publication-revue-pharmaceuticals-travaux 2022-06-09T15:05:10+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/professor-fabrice-andre-is-president-elect-of-the-european-society-for-medical 2022-07-07T10:43:39+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/professeur-fabrice-andre-est-elu-president-societe-europeenne 2022-07-07T10:43:39+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/florian-scotte-president-association-internationale-mascc 2022-07-06T10:06:00+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/grandes-esperances-guerir-cancer-lenfant-ladolescent 2022-09-15T17:09:43+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/gustave-roussy-a-lesmo-2022 2022-09-08T11:14:31+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2022-three-quarters-of-women-aged-less-than-40-treated-by 2022-10-07T15:35:46+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2022-chimiotherapie-cancer-du-sein-cycles-menstruels 2022-10-07T15:35:46+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2022-internal-vectorised-radiotherapy-is-effective-in 2022-10-07T15:35:04+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2022-radiotherapie-interne-vectorisee-efficace-tumeurs-neuro-endocrines-pancreas 2022-10-07T15:35:04+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2022-first-highly-targeted-therapy-against-the-fgfr2-gene 2022-10-07T15:36:35+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2022-premiere-therapie-ultra-ciblee-du-gene-fgfr-2 2022-10-07T15:36:35+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-top-3-mondial-hopitaux-cancerologie 2022-09-14T17:57:30+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/record-generosite-20-ans-dodyssea-paris 2022-10-04T10:05:37+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/octobre-rose-nest-pas-rose-programme-compass-contre-cancer 2022-10-05T13:59:03+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pr-fabrice-barlesi-est-nomme-president-matwin 2022-10-13T16:15:13+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cancer-du-sein-nouvelles-preuves-defficacite-du-sequencage 2022-11-08T11:29:33+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/lunite-adolescents-jeunes-adultes-gustave-roussy-fete-ses-20-ans 2022-11-28T17:10:17+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/the-paris-saclay-cancer-cluster-is-the-laureate-of-the-france-2030-biocluster 2022-12-05T13:49:17+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/paris-saclay-cancer-cluster-est-laureat-du-programme-biocluster 2022-12-05T13:49:17+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/servier-and-gustave-roussy-sign-a-framework-agreement-for-a-strategic 2022-12-14T18:12:16+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/servier-gustave-roussy-signent-contrat-cadre-collaboration-strategique 2022-12-14T18:12:16+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/sanofi-and-gustave-roussy-are-strengthening-their-strategic-oncology-research 2023-01-24T15:08:54+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/sanofi-gustave-roussy-renforcent-leur-collaboration 2023-01-24T15:08:54+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/promising-new-inhibitor-for-prostate-cancer-with-brca-mutations 2023-02-20T10:46:01+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nouvel-inhibiteur-prometteur-cancer-prostate-mutations-brca 2023-02-20T10:46:01+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/mars-bleu-cancers-digestifs-innovations-avancees-a-gustave 2023-02-24T10:52:20+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/epicure-le-nouveau-siric-de-gustave-roussy-dedie-epigenetique-labellise-par-linca 2023-06-07T16:09:55+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-is-launching-orakl-start-up-aiming-to-improve-and-accelerate 2024-07-12T16:04:27+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/creation-dorakl-spin-off-gustave-roussy-qui-vise-a-accelerer 2024-07-12T16:04:27+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/100-patients-traites-laide-du-nouveau-robot-epioner-a-gustave 2026-08-13T12:00:29+02:00 0.5 https://www.gustaveroussy.fr/en/press/innovation-ai-digital-health/france-is-set-to-become-a-global-leader-in-using-ai-to-diagnose 2023-03-31T12:05:10+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/owkin-lance-portrait-un-consortium-leader-mondial-ia 2023-03-31T12:05:10+02:00 0.5 https://www.gustaveroussy.fr/en/press/supportive-care-patient-support/an-innovative-technique-to-prevent-and-reduce-some-side 2023-04-12T13:28:15+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/technique-innovante-prevenir-reduire-certains-effets 2023-04-12T13:28:15+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/qualite-vie-au-travail-compass-group-france-met-place-frigos 2023-04-26T14:37:01+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/congres-laacr-lorigine-localisation-macrophages-tumeurs-sont 2023-06-07T16:23:17+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/aacr-congress-the-origin-and-location-of-the-macrophages-in-the 2023-04-20T10:08:13+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/centre-national-medecine-precision-prism-entre-nouvelle 2023-05-16T15:22:57+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/horizon-europe-programme-prevalung-eu-qui-developpe 2026-08-11T09:46:18+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/horizon-europe-the-prevalung-eu-program-which-develops-predictive-biomarkers 2026-03-26T15:32:22+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2023-urinary-tract-cancers-evidence-of-superiority-of 2026-08-13T10:15:36+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2023-cancers-voies-urinaires-preuve-superiorite-dune 2026-08-13T10:15:36+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/asco-2023-biomede-study-systematizes-molecular-profiling-to-guide 2026-08-13T10:16:28+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/asco-2023-letude-biomede-systematise-profilage-moleculaire-orienter-diagnostic 2026-08-13T10:16:28+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/cegedim-annonce-un-partenariat-davenir-avec-gustave-roussy 2023-06-02T11:04:26+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2023-predictive-biomarkers-of-efficacy-in-targeted 2026-08-13T10:17:10+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2023-bio-marqueurs-predictifs-lefficacite-dune 2026-08-13T10:17:10+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2023-metastatic-prostate-cancer-with-dna-repair-gene 2026-08-13T10:16:43+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2023-cancer-prostate-metastatique-porteurs-mutations 2026-08-13T10:16:43+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2023-benefits-of-radiotherapy-combined-with-abiraterone-and 2026-08-13T10:16:56+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2023-benefices-radiotherapie-associee-a-labiraterone 2026-08-13T10:16:56+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/groupe-tf1-lance-mobilisation-cancer-gustave-roussy 2023-06-07T16:19:35+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-theryq-premier-equipement-radiotherapie-flash-qui-traitera 2023-07-11T14:00:26+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/premier-equipement-radiotherapie-flash-qui-traitera-malades 2023-07-11T14:00:26+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/deux-enfants-atteints-dune-maladie-metabolique-genetique-traites-grace-a-molecule 2023-07-12T15:05:44+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/si-tous-enfants-pouvaient-devenir-grandes-personnes 2023-08-31T18:01:31+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/veracyte-and-gustave-roussy-announce-collaboration-to-help-biopharmaceutical 2023-09-07T14:37:07+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/veracyte-gustave-roussy-annoncent-nouvelle-collaboration-aider 2023-09-07T14:37:07+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/roche-france-foundation-medicine-and-the-institute-gustave-roussy-announce 2023-09-18T16:34:59+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/gustave-roussy-roche-foundation-medicine-annoncent 2023-09-18T16:34:59+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-in-the-worlds-top-5-cancer-hospitals 2023-09-28T18:06:03+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-top-5-mondial-hopitaux-cancerologie 2023-09-28T18:06:03+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/test-a-base-spheroides-predit-risque-personnaliser-traitements-enfants-atteints 2023-09-25T13:57:24+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2023 2023-10-23T09:07:29+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/paris-kids-cancer-nouveau-centre-integre-de-recherche-oncologie-pediatrique 2023-11-28T13:52:41+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/amgen-fonde-le-reseau-amgen-partners-choice-et-sassocie-gustave-roussy-et-sept-centres-de-recherche 2023-10-18T16:00:03+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2023-presentation-en-session-presidentielle-du-congres-europeen-doncologie-dr-julien-hadoux 2023-10-21T17:05:47+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2023-presentation-session-orale-pr-pierre-blanchard 2023-10-23T09:06:58+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2023-presentation-session-orale-dr-eric-baudin 2023-10-22T08:54:04+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/organoide-neuronal-equipe-dun-environnement-immunitaire 2026-08-11T09:44:57+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/a-neural-organoid-with-an-immune-environment 2023-11-16T10:46:30+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/sofinnova-partners-and-gustave-roussy-forge-strategic-alliance-to-boost 2023-12-13T09:56:33+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/sofinnova-partners-gustave-roussy-annoncent-partenariat 2023-12-13T09:56:33+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/partenariat-strategique-entre-gustave-roussy-et-lifen 2023-12-12T15:00:25+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/meditwin-reunit-lexcellence-sciences-technologies 2023-12-14T16:51:12+01:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/belzutifan-chef-file-dune-nouvelle-classe-therapeutique-tres 2023-12-15T18:15:20+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/cancer-du-pere-noel-gustave-roussy-lance-conte-noel-peu 2023-12-20T11:07:27+01:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/princesse-margot-lance-programme-culinaire-repas-toque-a 2023-12-21T10:22:53+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/the-department-of-therapeutic-innovation-and-early-stage-trials-strengthened-by 2024-01-22T10:32:20+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/departement-linnovation-therapeutique-essais-precoces-se-renforce-a-sa-tete 2024-01-22T10:32:20+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/dossier-presse-recherche-a-gustave-roussy 2024-01-25T10:56:20+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/revue-nature-vision-innovante-classification-cancers-est 2024-02-01T09:41:48+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/revue-nature-vision-innovante-classification-cancers-est-indispensable 2024-02-01T09:41:48+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/theryq-gustave-roussy-selectionnes-cadre-lappel-a-projets-i 2024-02-02T12:03:08+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/du-laboratoire-aux-essais-cliniques-guerir-le-cancer-enfant 2024-02-14T16:26:46+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/dana-farber-and-gustave-roussy-to-hold-third-transatlantic-exchange-annual 2024-02-28T11:38:50+01:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/mars-bleu-gustave-roussy-sengage-lutter-contre-hausse-cancers 2024-03-04T14:30:04+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/the-lancet-a-clinical-trial-proves-the-efficacy-of-sunitinib-in 2024-03-12T17:03:43+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/the-lancet-essai-clinique-prouve-lefficacite-du-sunitinib 2024-03-12T17:03:43+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/research-agreement-between-gustave-roussy-and-amgen-to-predict-the 2024-03-28T10:24:39+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/accord-recherche-entre-gustave-roussy-amgen-predire 2024-03-28T10:24:39+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/new-study-finds-triple-negative-breast-cancer-tumors-with-an 2024-04-03T12:15:11+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/publication-jama-risque-rechute-dun-cancer-du-sein-triple 2024-04-03T12:15:11+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/revue-cell-chercheurs-internationaux-posent-vision 2024-04-10T11:52:50+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/les-premiers-resultats-du-partenariat-entre-lifen-et-gustave-roussy-demontrent-force-ia 2024-04-12T11:32:29+02:00 0.5 https://www.gustaveroussy.fr/presse/decryptage/oncologie-sein-thyroide-poumon-digestif-gynecologie-succes-du-modele-diagnostic 2024-04-30T14:28:21+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/therasonic-a-cea-spin-off-created-end-of-2023-closes-a-fundraising-led-by-the 2024-05-14T12:05:19+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/therasonic-spin-off-du-cea-creee-fin-2023-clot-levee-fonds-menee 2024-05-14T12:05:19+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2024-promising-results-with-anti-trop2-drug-conjugated 2024-06-14T16:04:11+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2024-resultats-prometteurs-anticorps-conjugue 2024-06-14T16:04:11+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2024-early-screening-for-depressive-symptoms-in-breast 2024-06-14T16:05:32+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2024-depister-precocement-symptomes-depressifs-cancers 2024-06-14T16:05:32+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2024-virtual-biopsy-ia-can-be-used-to-map-the-response-of 2024-06-14T16:06:57+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2024-biopsie-virtuelle-lia-permet-faire-cartographie 2024-06-14T16:06:57+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2024-certain-socio-economic-factors-influence-adherence-to 2024-06-14T16:08:16+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2024-certains-facteurs-socio-economiques-influencent 2024-06-14T16:08:16+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/social-inequalities-widen-after-a-breast-cancer 2024-06-19T10:21:35+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/apres-cancer-du-sein-inegalites-sociales-se-creusent 2024-06-19T10:21:35+02:00 0.5 https://www.gustaveroussy.fr/presse/yan-pei-ming-donne-visage-a-linstitut-portrait-monumental-du-professeur-roussy 2024-10-10T10:29:49+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/presence-majeure-gustave-roussy-au-plus-grand-congres 2024-06-28T14:15:25+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/paris-kids-cancer-solution-aux-defis-loncologie-pediatrique 2024-09-10T10:24:47+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2024-new-hope-in-the-treatment-of-thymus-gland-cancers 2024-09-13T15:10:53+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2024-nouveaux-espoirs-prise-charge-cancers-du-thymus 2024-09-13T15:10:53+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2024-a-new-medically-promising-antibody-conjugate-for 2024-09-13T16:13:25+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2024-nouvel-anticorps-conjugue-medicament-prometteur 2024-09-13T16:13:25+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2024-metastatic-lung-cancer-new-therapeutic-avenues-are 2024-09-16T09:22:58+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2024-cancer-du-poumon-metastatique-nouvelles-pistes 2024-09-16T09:22:58+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2024-radiation-therapy-for-women-with-breast-cancer-will 2024-09-15T16:31:56+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2024-radiotherapie-femmes-atteintes-dun-cancer-du-sein 2024-09-15T16:31:56+02:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/esmo-2024-personalised-treatments-for-soft-tissue-sarcomas 2024-09-16T15:50:51+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2024-traitements-personnalises-contre-sarcomes-tissus 2024-09-16T15:50:51+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/gustave-roussy-inaugure-mycare-structure-unique-innovante 2024-09-25T11:31:40+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/50-nuances-rose-campagne-faire-progresser-personnalisation 2024-10-04T16:43:43+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/gustave-roussy-deploie-a-lechelle-nationale-profilage 2024-10-09T14:05:14+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/the-new-england-journal-of-medicine-premiere-fois-50-ans 2024-10-22T14:10:18+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cancer-discovery-decouverte-dun-nouveau-biomarqueur 2026-08-11T09:44:34+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/cancer-discovery-discovery-of-a-new-prognostic-biomarker-in-head 2026-03-26T15:53:16+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/launch-of-the-gustave-roussy-prize-to-honor-scientific-innovation-in-oncology 2024-11-20T14:38:45+01:00 0.5 https://www.gustaveroussy.fr/presse/prix-distinctions/lancement-du-prix-gustave-roussy-recompenser-linnovation-scientifique 2024-11-20T14:38:45+01:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/university-hospital-cologne-and-gustave-roussy-launch-franco 2024-11-27T15:02:47+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/guerbet-intrasense-gustave-roussy-and-the-university-hospital-of-angers-receive 2024-12-04T11:10:30+01:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/guerbet-intrasense-gustave-roussy-chu-dangers-obtiennent 2024-12-04T11:10:30+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/cancer-du-pere-noel-gustave-roussy-reprend-parole-son-conte 2024-12-06T12:23:33+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/presence-marquee-gustave-roussy-au-plus-grand-congres 2024-12-11T17:11:16+01:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/dana-farber-and-gustave-roussy-announce-2025-transatlantic-exchange-scientific 2026-08-11T10:52:45+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/dana-farber-gustave-roussy-annoncent-ledition-2025-transatlantic-exchange 2026-08-11T10:52:45+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/journee-mondiale-contre-cancer-2025-dossier-presse 2026-08-11T10:51:29+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/gustave-roussy-renforce-son-expertise-chirurgie-robot-assistee 2026-08-11T10:48:24+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/journee-mondiale-lutte-contre-cancer-gustave-roussy-invite 2026-08-11T10:45:47+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/resilience-and-the-department-of-therapeutic-innovation-and-early-stage-trials 2026-08-11T10:43:43+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/resilience-departement-dinnovation-therapeutique-essais-precoces-mettent 2026-08-11T10:43:43+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/the-inaugural-edition-of-the-gustave-roussy-prize-awarded-to-professor-charles 2026-08-11T10:17:52+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/ledition-inaugurale-du-prix-gustave-roussy-remise-au-pr-charles-swanton 2026-08-11T10:17:52+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/oasis-a-new-european-research-programme-to-optimise-antibody 2026-08-11T10:41:29+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/oasis-nouveau-programme-recherche-europeen-optimiser 2026-08-11T10:41:29+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cellules-allo-t-pas-plus-therapies-cellulaires 2025-02-10T10:16:11+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/the-lancet-benefices-radiotherapie-interne-vectorisee 2025-02-10T10:23:52+01:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/ameliorer-traitements-pediatriques-grace-a-limpression-3d 2026-08-11T10:39:49+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/paris-kids-cancer-accelere-recherche-onco-hematologie-pediatrique-ile-france 2025-02-14T13:51:33+01:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/gustave-roussy-lance-son-premier-concours-poesie-cadre-du 2026-08-11T10:37:38+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/blood-chercheurs-parviennent-a-reproduire-leucemie-pediatrique-a-partir-cellules 2026-08-11T10:35:59+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/sofinnova-partners-and-gustave-roussy-launch-first-biotech-company-through 2025-03-18T12:00:48+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/sofinnova-partners-gustave-roussy-annoncent-creation-premiere 2025-03-18T12:00:48+01:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/launch-of-the-european-programme-doselia-artificial-intelligence-in-the 2026-08-11T10:34:25+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/lancement-du-programme-europeen-doselia-lintelligence-artificielle-au-service 2026-08-11T10:34:25+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/gustave-roussy-is-exporting-its-model-of-excellence-internationally-with-a 2026-08-11T10:32:56+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-exporte-son-modele-dexcellence-a-linternational-premier 2026-08-11T10:32:56+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/age-related-genetic-changes-in-the-blood-associated-with-poor 2026-08-11T10:31:42+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/alterations-genetiques-liees-a-lage-sang-associees-a 2026-08-11T10:31:42+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/the-presence-of-tumour-dna-in-the-blood-could-shape-follow-up 2026-08-11T10:30:14+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/presence-dadn-tumoral-sang-pourrait-determiner-suivi 2026-08-11T10:30:14+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2025-a-combination-therapy-shows-signs-of-efficacy-in 2026-08-11T10:28:53+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2025-association-therapeutique-montre-signes 2026-08-11T10:28:53+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/asco-2025-for-the-first-time-in-20-years-a-new-treatment-shows 2026-08-11T10:27:35+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/asco-2025-premiere-fois-20-ans-nouveau-traitement-prouve 2026-08-11T10:27:35+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/asco-2025-a-new-drug-tested-as-a-first-line-treatment-for-poor-prognosis 2026-08-11T10:28:17+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/asco-2025-nouveau-medicament-teste-premiere-ligne-sarcomes-dewing-mauvais 2026-08-11T10:28:17+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/ifods-2025-partenariat-inedit-entre-gustave-roussy-congres 2025-06-10T15:32:33+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/moins-dun-apres-son-lancement-le-parcours-fresh-etend-lacces-la-medecine-de-precision 2026-08-11T10:26:15+02:00 0.5 https://www.gustaveroussy.fr/en/press/innovation-ai-digital-health/aitia-and-gustave-roussy-join-forces-to-identify-the-fundamental 2025-06-16T17:10:59+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/radiotherapie-interne-vectorisee-riv-theranostic 2026-08-11T10:24:57+02:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/projet-loi-finances-2026-affaiblir-dons-recherche-biomedicale-cest 2026-08-11T10:21:13+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/le-professeur-benjamin-besse-elu-la-presidence-de-eortc 2026-08-11T10:19:37+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/septembre-recherche-ambitieuse-defier-pronostic-cancers 2026-08-11T10:14:20+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/the-lancet-progres-patients-atteints-dun-cancer-du-poumon 2026-08-11T10:12:49+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/nature-medicine-a-new-antibody-drug-conjugate-shows-promising 2026-08-11T09:04:19+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nature-medicine-conjugue-anticorps-medicament-montre 2026-08-11T09:04:19+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/brancardiers-inventent-dispositif-astucieux-faciliter-deplacements-patients 2026-08-11T10:02:09+02:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/octobre-rose-donner-a-chaque-femme-lopportunite-se 2026-08-11T10:11:29+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2025-when-the-tumour-microenvironment-hinders-the 2026-08-11T10:08:57+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2025-quand-microenvironnement-tumoral-freine 2026-08-11T10:08:57+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/esmo-2025-can-cancer-be-prevented-with-medication-a-look-back-at 2026-08-11T10:07:55+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/esmo-2025-prevenir-cancer-medicaments-retour-40-annees 2026-08-11T10:07:55+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-finalise-le-financement-de-son-futur-batiment-de-recherche 2026-08-11T10:04:00+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/pr-christophe-tourneau-est-nomme-directeur-general-adjoint 2025-11-03T18:04:23+01:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/boehringer-ingelheim-et-gustave-roussy-annoncent-un-partenariat-strategique 2026-08-11T09:17:40+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/new-advances-in-the-management-of-blood-cancers-presented-at-the 2025-12-08T13:58:14+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nouvelles-avancees-prise-en-charge-cancers-du-sang-presentees-au-congres-ash 2025-12-08T13:58:14+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/gustave-roussy-lance-soutien-dinfopro-digital-guide-travail-cancer 2025-12-15T10:56:39+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/lia-associee-a-lexpertise-humaine-va-transformer-collecte 2025-12-18T12:44:08+01:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/gustave-roussy-renforce-son-leadership-medecine-precision 2026-08-11T09:24:09+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/gustave-roussy-lansm-permettent-a-patients-atteints-dun-cancer-rare-acces-securise 2026-01-09T09:50:27+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/guerir-cancer-commence-aujourdhui 2026-08-11T09:53:37+02:00 0.5 https://www.gustaveroussy.fr/presse/temoignages/vie-plus-guerir-cancer 2026-10-04T17:47:11+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/lia-oncologie-lhumain-augmente-au-service-du-soin-recherche 2026-01-20T16:42:21+01:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/avec-son-nouveau-projet-etablissement-gustave-roussy-reaffirme-son-ambition 2026-08-11T09:51:45+02:00 0.5 https://www.gustaveroussy.fr/en/press/awards-honours/the-2026-edition-of-the-gustave-roussy-prize-awarded-to-prof-luis-diaz-jr 2026-08-11T09:43:15+02:00 0.5 https://www.gustaveroussy.fr/presse/prix-distinctions/ledition-2026-du-prix-gustave-roussy-remise-au-pr-luis-diaz-jr 2026-08-11T09:43:15+02:00 0.5 https://www.gustaveroussy.fr/presse/soins-support-accompagnement/apres-le-succes-de-la-1re-edition-gustave-roussy-reconduit-son-concours-de-poesie 2026-08-11T09:20:01+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/journee-internationale-cancers-lenfant-paris-kids-cancer-soutient-nouveaux-projets 2026-02-16T10:10:35+01:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/the-lancet-the-standard-radiotherapy-treatment-for-breast-cancer 2026-08-11T09:41:34+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/the-lancet-traitement-standard-radiotherapie-cancers-du 2026-08-11T09:41:34+02:00 0.5 https://www.gustaveroussy.fr/en/press/campaigns-community-outreach/colorectal-cancer-awareness-month-from-organoids-to-surgery 2026-03-12T16:55:02+01:00 0.5 https://www.gustaveroussy.fr/presse/campagnes-mobilisation-solidaire/mars-bleu-organoides-a-chirurgie-gustave-roussy-a-pointe 2026-03-12T16:55:02+01:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/fifth-transatlantic-exchange-oncology-collaborative-approach-delivering-excellence 2026-03-24T09:01:31+01:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/recobia-therapeutics-and-gustave-roussy-transfert-join-forces 2026-08-11T09:39:21+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/recobia-therapeutics-gustave-roussy-transfert-sallient-accelerer 2026-08-11T09:39:21+02:00 0.5 https://www.gustaveroussy.fr/en/press/public-health-prevention/interception-receives-6-million-euros-in-funding-a-decisive-step 2026-08-11T09:37:49+02:00 0.5 https://www.gustaveroussy.fr/presse/sante-publique-prevention/interception-recoit-financement-6-millions-deuros-etape-decisive 2026-08-11T09:37:49+02:00 0.5 https://www.gustaveroussy.fr/presse/innovation-ia-sante-numerique/nouvel-outil-dia-au-service-dune-detection-optimale-du-cancer 2026-08-11T09:33:39+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/cancer-cell-a-french-study-reveals-the-mechanism-of-action-of-an 2026-08-11T09:32:14+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/cancer-cell-etude-francaise-perce-mecanisme-daction-dun 2026-08-11T09:32:14+02:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/a-novel-triple-therapy-shows-promising-signs-of-efficacy-in 2026-08-11T09:28:44+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/nouvelle-tritherapie-montre-signes-defficacite-prometteurs 2026-08-11T09:28:44+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/nature-medicine-a-major-international-clinical-trial-sheds-new-light-on-a 2026-04-24T16:00:38+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/nature-medicine-vaste-essai-clinique-international-apporte-eclairage-inedit-cancer 2026-04-24T16:00:38+02:00 0.5 https://www.gustaveroussy.fr/en/press/clinical-scientific-advances/nature-intra-tumour-immunotherapy-mobilising-the-immune-system 2026-08-11T09:25:54+02:00 0.5 https://www.gustaveroussy.fr/presse/avancees-cliniques-scientifiques/nature-immunotherapie-intratumorale-mobiliser-limmunite 2026-08-11T09:25:54+02:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/kahimmune-therapeutics-signs-agreement-for-scientific 2026-08-11T09:12:53+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/kahimmune-therapeutics-signe-accord-collaboration-scientifique 2026-08-11T09:12:53+02:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/asco-2026-an-antibody-drug-conjugate-shows-promising-signs-of 2026-05-30T07:01:04+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/asco-2026-anticorps-conjugue-medicament-efficacite-cancers-uterus 2026-05-30T07:01:04+02:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/asco-2026-pioneering-tumour-mapping-to-guide-the-choice-of 2026-08-11T09:22:23+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/asco-2026-cartographie-inedite-tumeurs-guider-choix 2026-08-11T09:22:23+02:00 0.5 https://www.gustaveroussy.fr/en/press/congresses-conferences-events/gustave-roussy-and-the-lancet-launch-a-landmark-international 2026-10-04T18:38:07+02:00 0.5 https://www.gustaveroussy.fr/presse/congres-conferences-rencontres/gustave-roussy-the-lancet-lancent-conference-internationale 2026-10-04T18:38:07+02:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/launch-new-interuniversity-diploma-diu-personalized-cancer 2026-07-16T11:42:39+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/ouverture-dun-nouveau-diplome-inter-universitaire-diu-prevention 2026-07-16T11:42:39+02:00 0.5 https://www.gustaveroussy.fr/en/press/partnerships-health-economics/owkin-and-gustave-roussy-partner-bring-k-pro-real-world 2026-07-21T17:25:23+02:00 0.5 https://www.gustaveroussy.fr/presse/partenariats-economie-sante/owkin-gustave-roussy-sassocient-deployer-k-pro-pratique-clinique 2026-07-21T17:25:23+02:00 0.5 https://www.gustaveroussy.fr/en/press/patronage-philanthropy/route-du-rhum-2026-jean-le-cam-and-christophe-rateau-sail-gustave 2026-07-28T14:13:41+02:00 0.5 https://www.gustaveroussy.fr/presse/mecenat-philanthropie/route-du-rhum-2026-jean-cam-christophe-rateau-navigueront-gustave 2026-07-28T14:13:41+02:00 0.5 https://www.gustaveroussy.fr/en/press/institutional/prof-fabrice-barlesi-reappointed-head-gustave-roussy-leading-cancer-center 2026-08-11T09:13:43+02:00 0.5 https://www.gustaveroussy.fr/presse/institutionnel/pr-fabrice-barlesi-renouvele-a-tete-gustave-roussy-premier-centre-lutte 2026-08-11T09:13:43+02:00 0.5 https://www.gustaveroussy.fr/en/press/paediatric-oncology/gold-september-two-new-research-programmes-launched-tackle-childhood 2026-09-08T17:49:27+02:00 0.5 https://www.gustaveroussy.fr/presse/pediatrie/septembre-lancement-deux-nouveaux-programmes-recherche-dedies-aux-cancers 2026-09-08T17:49:27+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/genomics-and-oncogenesis-of-pediatric-brain-tumors 2026-09-25T11:55:27+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/genomique-oncogenese-tumeurs-cerebrales-pediatriques 2026-09-25T11:55:27+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/tumor-plasticity-during-cancer-therapy 2026-09-24T20:40:03+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/plasticite-tumorale-therapie-anti-cancereuse 2026-09-24T20:40:03+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/adaptive-resistance 2026-09-24T08:07:57+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/resistance-adaptative 2026-09-24T08:07:57+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/molecular-characterization-of-breast-and-gynecologic-cancers 2026-09-24T18:28:46+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/caracterisation-moleculaire-cancers-du-sein-gynecologiques 2026-09-24T18:28:46+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/genetic-and-epigenetic-vulnerabilities-of-solid-tumors-and-sarcomas 2026-09-24T20:41:01+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/vulnerabilites-genetiques-epigenetiques-tumeurs-solides-sarcomes 2026-09-24T20:41:01+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/inflammation-and-tumor-plasticity 2026-09-24T07:58:43+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/inflammation-plasticite-tumorale 2026-09-24T07:58:43+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/molecular-dynamics-of-hematopoietic-transformation 2026-09-24T08:04:37+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/dynamique-moleculaire-transformation-hematopoietique 2026-09-24T08:04:37+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/genetics-and-biology-of-thyroid-cancers 2026-09-24T14:54:01+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/genetique-biologie-cancers-thyroide 2026-09-24T14:54:01+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/cancer-survivorship 2026-09-24T09:32:57+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/cancer-survivorship 2026-09-24T09:32:57+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/epirad-understanding-the-long-term-effects-of-cancer-treatments-and-radiation 2026-09-24T09:32:12+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/epirad-comprendre-effets-tardifs-traitements-anticancereux-expositions-aux 2026-09-24T09:32:12+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/exposome-heredity-cancer-and-health 2026-09-24T09:48:48+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/exposome-heredite-cancer-sante 2026-09-24T09:48:48+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/oncostat 2026-09-24T09:32:26+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/oncostat 2026-09-24T09:32:26+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/endocytosis-cytoskeleton-and-cell-migration 2026-09-24T09:39:44+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/endocytose-cytosquelette-migration-cellulaire 2026-09-24T09:39:44+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/cell-biology-of-organelle-networks 2026-09-24T09:40:19+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-cellulaire-reseaux-dorganites 2026-09-24T09:40:19+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/cellular-biology-of-advanced-gastrointestinal-cancers 2026-09-24T09:38:48+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-cellulaire-cancers-digestifs-avances 2026-09-24T09:38:48+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/aging-of-the-hematopoietic-tissue 2026-09-24T09:43:09+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/vieillissement-du-tissu-hematopoietique 2026-09-24T09:43:09+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/from-hematopoietic-stem-cells-to-megakaryocytes 2026-09-24T09:48:15+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/cellule-souche-hematopoietique-au-megacaryocyte 2026-09-24T09:48:15+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/antitumor-immunity-of-t-cells-and-cancer-immunotherapy 2026-09-24T10:00:32+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/immunite-antitumorale-lymphocytes-t-immunotherapie-du-cancer 2026-09-24T10:00:32+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/advanced-cell-therapies 2026-09-24T20:48:35+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/therapies-cellulaires-avancees 2026-09-24T20:48:35+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/in-vivo-reprogramming-of-antitumor-immunity 2026-09-24T20:44:59+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/reprogrammation-in-vivo-limmunite-antitumorale 2026-09-24T20:44:59+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/translational-immunotherapy-research-laboratory-lrti 2026-09-24T10:07:52+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/laboratoire-recherche-translationnelle-immunotherapie-lrti 2026-09-24T10:07:52+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/biology-of-myeloid-cells-and-cancer 2026-09-24T20:44:36+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-cellules-myeloides-cancer 2026-09-24T20:44:36+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/biology-of-malignant-blood-disorders-in-children 2026-09-25T13:34:52+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-hemopathies-malignes-lenfant 2026-09-25T13:34:52+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/integrated-genomics-of-pediatric-cancers 2026-09-25T13:33:24+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/genomique-integree-cancers-pediatriques 2026-09-25T13:33:24+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/biology-treatments-drug-resistant-cancers-children 2026-09-28T15:38:33+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-therapeutiques-cancers-resistants-lenfant 2026-09-28T15:38:33+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/translational-cancer-genomics 2026-09-24T10:16:33+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/genomique-translationnelle-du-cancer 2026-09-24T10:16:33+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/computational-clinical-oncology 2026-09-24T20:47:59+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/oncologie-clinique-computationnelle 2026-09-24T20:47:59+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/cell-reprogramming-immunity-and-innovative-biotherapies 2026-09-24T13:46:51+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/reprogrammation-cellulaire-immunite-biotherapies-innovantes 2026-09-24T13:46:51+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/nanomedicine 2026-09-24T21:06:37+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/nanomedecine 2026-09-24T21:06:37+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/metabolic-plasticity-in-cancer 2026-09-24T21:09:59+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/plasticite-metabolique-cancer 2026-09-24T21:09:59+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/host-tumor-interactions-aerodigestive-tract-carcinomas-investigation-and-therapeutic 2026-09-29T10:07:44+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/interactions-hote-tumeur-carcinomes-voies-aeriennes-aerodigestives-exploration 2026-09-29T10:07:44+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/analysis-of-cellular-metabolism 2026-09-24T21:12:29+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/analyse-du-metabolisme-cellulaire 2026-09-24T21:12:29+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/repair-of-double-strand-breaks-replicative-stress-and-genome-integrity 2026-09-24T21:06:02+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/reparation-cassures-double-brin-stress-replicatif-integrite-du-genome 2026-09-24T21:06:02+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/genome-dynamics-and-stability 2026-09-24T21:05:39+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/dynamique-stabilite-du-genome 2026-09-24T21:05:39+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/dna-repair-adp-ribosylation-and-cancer 2026-09-24T21:04:49+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/reparation-ladn-adp-ribosylation-cancer 2026-09-24T21:04:49+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/genome-replication-and-the-epigenome 2026-09-24T21:03:25+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/replication-du-genome-epigenome 2026-09-24T21:03:25+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/genotoxic-stress-monitoring-of-genome-integrity-and-cancer 2026-09-24T21:04:38+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/stress-genotoxiques-surveillance-lintegrite-du-genome-cancers 2026-09-24T21:04:38+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/gustave-roussy-cellular-and-molecular-electron-microscopy-platform 2026-09-24T17:27:07+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/plateforme-microscopie-electronique-cellulaire-moleculaire-gustave-roussy 2026-09-24T17:27:07+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/oncomaps 2026-09-29T11:33:45+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/oncomaps 2026-09-29T11:33:45+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/molecular-radiotherapy-and-therapeutic-innovations 2026-09-28T19:05:21+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/radiotherapie-moleculaire-innovations-therapeutiques 2026-09-28T19:05:21+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/biomathematics 2026-09-24T10:17:38+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biomathematiques 2026-09-24T10:17:38+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/computational-biology-cancer 2026-09-28T19:00:28+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-computationnelle-du-cancer 2026-09-28T19:00:28+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/mitochondrial-cell-biology-and-pharmacology 2026-09-24T21:11:24+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/biologie-cellulaire-mitochondriale-pharmacologie 2026-09-24T21:11:24+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/microbiota-and-mucosal-immunity-in-the-context-of-cancer-immunotherapy 2026-09-24T20:52:16+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/microbiote-immunite-mucosale-cadre-limmunotherapie-anticancereuse 2026-09-24T20:52:16+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/the-role-of-chromatin-in-dna-repair 2026-09-24T21:04:16+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/role-chromatine-reparation-ladn 2026-09-24T21:04:16+02:00 0.5 https://www.gustaveroussy.fr/en/research-teams/translesional-polymerases-genomic-plasticity-and-cancer 2026-09-24T21:05:03+02:00 0.5 https://www.gustaveroussy.fr/equipes-recherche/polymerases-translesionnelles-plasticite-du-genome-cancers 2026-09-24T21:05:03+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1360-oncogenesis 2026-09-25T11:19:25+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1360-oncogenese 2026-09-25T11:19:25+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u981-molecular 2026-09-24T18:26:17+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u981-predicteurs 2026-09-24T18:26:17+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1018-research-center 2026-09-24T20:44:09+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1018-centre-recherche 2026-09-24T20:44:09+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1279-tumor-cell 2026-09-23T13:03:50+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1279-dynamique 2026-09-23T13:03:50+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1287-hematopoietic-stem 2026-09-24T09:42:02+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1287-cellules-souches 2026-09-24T09:42:02+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1355-molecular 2026-09-24T18:18:08+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1355-radiotherapie 2026-09-24T18:18:08+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1356-research-and 2026-09-24T09:57:14+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1356-recherche 2026-09-24T09:57:14+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1361-cancer-data 2026-09-24T20:47:25+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1361-cancer-data 2026-09-24T20:47:25+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1363-innovative 2026-09-24T13:40:26+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1363-biotherapies 2026-09-24T13:40:26+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/u1367-microbiota-and 2026-09-24T20:53:13+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/u1367-microbiote 2026-09-24T20:53:13+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/umr9018-cancer-biology 2026-09-24T21:07:20+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/umr9018-biologie-du 2026-09-24T21:07:20+02:00 0.5 https://www.gustaveroussy.fr/en/recherche-innovation/recherche-gustave-roussy/unites-thematiques-recherche/umr9019-genome-integrity 2026-09-24T21:02:43+02:00 0.5 https://www.gustaveroussy.fr/recherche-innovation/recherche-a-gustave-roussy/unites-thematiques-recherche/umr9019-integrite-du 2026-09-24T21:02:43+02:00 0.5 https://www.gustaveroussy.fr/u1281-umr-9011-biomaps-laboratoire-dimagerie-biomedicale 2026-10-02T13:56:43+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/colorectal-cancer 2026-10-04T19:12:41+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-colorectal 2026-10-04T19:12:41+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/prostate-cancer 2026-10-03T11:39:33+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-prostate 2026-10-03T11:39:33+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/bladder-cancer 2026-10-03T11:37:02+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-vessie 2026-10-03T11:37:02+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/thyroid-cancer 2026-10-04T19:41:40+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-thyroide 2026-10-04T19:41:40+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/pancreatic-cancer 2026-10-03T11:32:11+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-pancreas 2026-10-03T11:32:11+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/lung-cancer 2026-10-02T16:50:52+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-poumon 2026-10-02T16:50:52+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/kidney-cancer 2026-10-03T10:29:25+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-rein 2026-10-03T10:29:25+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/skin-cancer 2026-10-03T14:01:36+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-peau 2026-10-03T14:01:36+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-prevention/types-of-cancer/stomach-cancer 2026-10-02T16:50:36+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-estomac 2026-10-02T16:50:36+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/gynecological-cancers 2026-10-04T19:42:34+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancers-gynecologiques 2026-10-04T19:42:34+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/liver-cancer 2026-10-03T10:42:48+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-foie 2026-10-03T10:42:48+02:00 0.5 https://www.gustaveroussy.fr/hold-sarcomes 2026-09-11T14:26:33+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/testicular-cancer 2026-10-03T10:45:13+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-testicule 2026-10-03T10:45:13+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/ent-cancers 2026-10-03T10:47:02+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancers-orl 2026-10-03T10:47:02+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/rare-cancers 2026-10-03T11:00:03+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancers-rares 2026-10-03T11:00:03+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/adrenal-tumors 2026-10-04T19:42:04+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/tumeurs-surrenale 2026-10-04T19:42:04+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/breast-cancer 2026-10-02T16:54:14+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancer-du-sein 2026-10-02T16:54:14+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-of-cancer/sarcomas 2026-10-02T15:42:46+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/sarcomes 2026-10-02T15:42:46+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/brain-tumors 2026-10-03T11:12:13+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/tumeurs-du-cerveau 2026-10-03T11:12:13+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/neuroendocrine-tumors 2026-10-03T11:19:15+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/tumeurs-neuroendocrines 2026-10-03T11:19:15+02:00 0.5 https://www.gustaveroussy.fr/en/cancer-and-prevention/types-cancer/hematologic-cancers 2026-10-03T14:32:16+02:00 0.5 https://www.gustaveroussy.fr/cancer-prevention/types-cancer/cancers-hematologiques 2026-10-03T14:32:16+02:00 0.5